Leonteq Securities AG’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
20,528
+11,027
+116% +$193K 0.01% 489
2026
Q1
$182K Buy
9,501
+1,695
+22% +$36.8K 0.01% 620
2025
Q4
$172K Sell
7,806
-3,236
-29% -$58.4K 0.01% 701
2025
Q3
$134K Buy
11,042
+5,151
+87% +$69.7K ﹤0.01% 685
2025
Q2
$110K Sell
5,891
-957
-14% -$19K ﹤0.01% 703
2025
Q1
$131K Buy
6,848
+4,082
+148% +$119K 0.01% 638
2024
Q4
$99.6K Buy
2,766
+1,644
+147% +$55.6K 0.01% 690
2024
Q3
$47.6K Hold
1,122
﹤0.01% 765
2024
Q2
$45.2K Buy
+1,122
New +$46.8K ﹤0.01% 783
2023
Q3
Sell
-6,512
Closed -$160K 1292
2023
Q2
$160K Buy
6,512
+1,512
+30% +$48.6K 0.01% 581
2023
Q1
$203K Buy
5,000
+3,000
+150% +$124K 0.01% 521
2022
Q4
$89.9K Sell
2,000
-28
-1% -$1.27K ﹤0.01% 691
2022
Q3
$97K Sell
2,028
-441
-18% -$24.2K ﹤0.01% 649
2022
Q2
$146K Buy
2,469
+1,179
+91% +$96.8K 0.01% 607
2022
Q1
$150K Hold
1,290
0.01% 650
2021
Q4
$194K Buy
+1,290
New +$174K 0.01% 632
2021
Q3
Sell
-800
Closed -$77.9K 1222
2021
Q2
$77.9K Hold
800
﹤0.01% 769
2021
Q1
$70.6K Hold
800
﹤0.01% 744
2020
Q4
$76.5K Buy
+800
New +$82.4K ﹤0.01% 721

Other funds holding TNDM

Leonteq Securities AG's TNDM Position: Q2 2026 in Review

Leonteq Securities AG increased its Tandem Diabetes Care (TNDM) stake by 116% in Q2 2026, buying an estimated $193K and bringing the position to 20,528 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #489.

Leonteq Securities AG first reported a position in TNDM in Q4 2020 and has held it in 19 quarters since. 272 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Leonteq Securities AG held 20,528 shares of Tandem Diabetes Care worth $310K as of Q2 2026.
  • Leonteq Securities AG bought 11,027 Tandem Diabetes Care shares in Q2 2026, an estimated $193K.
  • Tandem Diabetes Care made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #489 holding.
  • Leonteq Securities AG first reported a position in Tandem Diabetes Care in Q4 2020 and has held it in 19 quarters since.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.